Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.
(2) Dr. Debarshi Kar Mahapatra, Assistant Professor, Dadasaheb Balpande College of Pharmacy Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India.
Reviewers:
(1) Kiril Stefanov Slaveykov, Trakia University, Bulgaria.
(2) Manoj Kumar Saurabh, All India Institute of Medical Sciences, India.
(3) Manoranjan Dash, Siksha O Anusandhan University, India.
Additional Reviewers:
(1) Hanifah Rahmi Fajrin, Universitas Muhammadiyah Yogyakarta, Indonesia.
(2) Mudasir M Kirmani, SK Unviersity of Agricultural Sciences and technology of Kashmir, India.
(3) Zvezdan Stojanović, PIM University and European University, Bosnia and Herzegovina.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Kiril Stefanov Slaveykov, Bulgaria) | File 1 | File 2
Stage 2 | Peer review report_2 (Manoj Kumar Saurabh, India) | File 1 | NA
Stage 2 | Peer review report_3 (Manoranjan Dash, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA